Cargando…

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients

Targeting the PD-1/PD-L1 immune checkpoint signaling is a novel promising treatment strategy in several tumor entities, and it is suggested that PD-L1/PD-1 expression is predictive for a PD-1/PD-L1 checkpoint inhibitor treatment response. We investigated the expression of PD-L1 and PD-1 by immunohis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böger, Christine, Behrens, Hans-Michael, Mathiak, Micaela, Krüger, Sandra, Kalthoff, Holger, Röcken, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029700/ https://www.ncbi.nlm.nih.gov/pubmed/27009855 http://dx.doi.org/10.18632/oncotarget.8169

Ejemplares similares

The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
por: Böger, Christine, et al.
Publicado: (2017)

Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization
por: Mathiak, Micaela, et al.
Publicado: (2017)

Integrins α(v)β(3) and α(v)β(5) as prognostic, diagnostic, and therapeutic targets in gastric cancer
por: Böger, Christine, et al.
Publicado: (2014)

Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer
por: Wilhelm, Franziska, et al.
Publicado: (2016)

Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort
por: Röcken, Christoph, et al.
Publicado: (2016)

MET in gastric cancer – discarding a 10% cutoff rule
por: Metzger, Marie‐Luise, et al.
Publicado: (2015)

Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
por: Böger, C., et al.
Publicado: (2017)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)

Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule
por: Behrens, Hans-Michael, et al.
Publicado: (2015)

The putative pleiotropic functions of meprin β in gastric cancer
por: Siemsen, Wiebke, et al.
Publicado: (2023)

Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women
por: Clausen, Franziska, et al.
Publicado: (2019)

Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
por: Dottermusch, Matthias, et al.
Publicado: (2019)

The Spatial Distribution of LGR5(+) Cells Correlates With Gastric Cancer Progression
por: Simon, Eva, et al.
Publicado: (2012)

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
por: Gundlach, Jan-Paul, et al.
Publicado: (2018)

The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent
por: Holm, Bente, et al.
Publicado: (2023)

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort
por: Schrumpf, Thorben, et al.
Publicado: (2022)

Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell Density
por: Ulase, Dita, et al.
Publicado: (2021)

SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1 / ERBB2 co‐amplification
por: Pries, Katharina, et al.
Publicado: (2023)

Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
por: Warneke, V S, et al.
Publicado: (2013)

LAG3 in gastric cancer: it’s complicated
por: Ulase, Dita, et al.
Publicado: (2023)

Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer
por: Hoffmann, Anne, et al.
Publicado: (2021)

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response
por: Freiin Grote, Antonia, et al.
Publicado: (2019)

The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications
por: Heckl, Steffen M., et al.
Publicado: (2019)

Therapy Resistance in Neoadjuvantly Treated Gastric Cancer and Cancer of the Gastroesophageal Junction is Associated with an Increased Expression of Immune Checkpoint Inhibitors—Comparison Against a Therapy Naïve Cohort
por: Schoop, Hauke, et al.
Publicado: (2019)

Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma
por: Kock am Brink, Magnus, et al.
Publicado: (2022)

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
por: Beckinger, Silje, et al.
Publicado: (2023)

Epithelial insulin receptor expression–prognostic relevance in colorectal cancer
por: Heckl, Steffen M., et al.
Publicado: (2018)

Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
por: Albrecht, Thomas, et al.
Publicado: (2021)

Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
por: Röcken, Christoph, et al.
Publicado: (2021)

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
por: Warneke, V. S., et al.
Publicado: (2013)

Amyloid in biopsies of the gastrointestinal tract—a retrospective observational study on 542 patients
por: Freudenthaler, Sophie, et al.
Publicado: (2016)

Questioning the IGF1 receptor’s assigned role in CRC – a case for rehabilitation?
por: Heckl, Steffen M., et al.
Publicado: (2020)

The age-specific differences in histopathological tumor characteristics and TNM classification of breast carcinomas in Quality assured mamma diagnostic (QuaMaDi) program in the state of Schleswig–Holstein in Germany
por: Kramp, L.-J., et al.
Publicado: (2021)

Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study
por: Romagnoli, Gloria, et al.
Publicado: (2017)

Smoking-Induced SLPI Expression Hinders HPV Infections Also in Squamous Cell Carcinomas of the Vulva
por: Quabius, Elgar S., et al.
Publicado: (2018)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022)

PD-L1(P146R) is prognostic and a negative predictor of response to immunotherapy in gastric cancer
por: Li, Qing, et al.
Publicado: (2022)

Interpreting whole genome and exome sequencing data of individual gastric cancer samples
por: Esser, Daniela, et al.
Publicado: (2017)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
por: Daunke, Tina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3rft5lusegj2u8cub3gdimnqar